Good morning :)
Place Order
Add to Watchlist

Entero Healthcare Solutions Ltd

ENTERO

Entero Healthcare Solutions Ltd

ENTERO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,354 cr, stock is ranked 721
High RiskStock is 3.11x as volatile as Nifty
1,463.700.16% (+2.35)
1,463.700.16% (+2.35)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,354 cr, stock is ranked 721
High RiskStock is 3.11x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹6,354 cr, stock is ranked 721
High RiskStock is 3.11x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
88.943.87
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.536.560.52%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 3 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Entero Healthcare Solutions is an India-based technology-driven and integrated healthcare products distribution company.

Investor Presentation

View older 

Nov 13, 2024

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2021FY 2022FY 2023FY 2024TTM
Total Revenue1,783.672,526.553,305.723,936.724,460.19
Raw Materialssubtract1,685.192,342.473,051.263,627.814,294.43
Power & Fuel Costsubtract3.394.074.255.60
Employee Costsubtract75.94114.81128.14151.15
Selling & Administrative Expensessubtract21.3133.7555.1965.24
Operating & Other expensessubtract-27.642.53-2.64-39.34
Depreciation/Amortizationsubtract16.2819.7524.2425.0227.23
Interest & Other Itemssubtract20.0428.9848.9765.6854.55
Taxes & Other Itemssubtract4.6910.107.87-3.5512.53
EPS-1,549.90-151.44-29.0416.4316.43
DPS0.000.000.000.000.00
Payout ratio0.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025

Annual Report Pending

Investor Presentation

Nov 13PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Entero Healthcare Solutions Ltd162.483.87
Sun Pharmaceutical Industries Ltd45.356.470.75%
Cipla Ltd28.514.380.89%
Torrent Pharmaceuticals Ltd68.4516.540.84%

Price Comparison

Compare ENTERO with any stock or ETF
Compare ENTERO with any stock or ETF
ENTERO
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Decreased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 1.16%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding52.44%5.07%2.66%23.82%16.01%

Feb 2024

Mar 2024

Jun 2024

Sep 2024

Shareholding History

SepFebMarJunSep0.00%22.80%23.30%23.32%23.82%

Mutual Funds Holding Trend

Increased Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 5.07%

Top 5 Mutual Funds holding Entero Healthcare Solutions Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Invesco India Contra Fund - Growth - Direct Plan

Growth
2.6631%0.96%0.65%42/78 (+32)
Invesco India Smallcap Fund - Growth - Direct Plan

Growth
0.8482%0.92%0.36%69/85 (+5)
Invesco India ELSS Tax Saver Fund - Growth - Direct Plan

Growth
0.4790%1.03%1.03%58/69 (+6)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

ENTERO has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Earnings
Entero Healthcare Solutions consolidated net profit rises 360.43% in the September 2024 quarter

Net profit of Entero Healthcare Solutions rose 360.43% to Rs 23.62 crore in the quarter ended September 2024 as against Rs 5.13 crore during the previous quarter ended September 2023. Sales rose 30.55% to Rs 1300.69 crore in the quarter ended September 2024 as against Rs 996.30 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1300.69996.30 31 OPM %3.262.87 - PBDT42.2712.75 232 PBT34.786.82 410 NP23.625.13 360 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Entero Healthcare Solutions schedules board meeting

Entero Healthcare Solutions will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
Entero Healthcare soars after India Ratings upgrades rating to 'A-'

India Ratings and Research stated that the rating upgrade reflects continued strong growth in Entero group's scale of operations and operating profitability in FY24, with significant growth in its revenue and an improvement in the EBITDA margin and Ind-Ra's expectation of further growth in FY25 and over the medium term, backed by the heavy capital infusion into the company. In February 2024, Entero raised Rs 1,000 crore from its initial public offer (IPO) for funding expansion through acquisitions and managing its intense working capital requirement over the medium term. Backed by the unutilised amounts from the IPO proceeds, the group was net cash positive at FYE24 with a significant reduction in its overall debt levels due to the full repayment of Entero's long-term debt in March 2024. The continued expansion into newer geographies strengthening its pan-India presence and growth in customer and product portfolio during the year also support the rating. The rating is, however, constrained by the inherent limitations of distributorship and the inherent risks of the pharmaceuticals industry. The negative free cash flows since inception, and the group's brief track record of operations also constrain the rating. Entero Healthcare Solutions is a supply-chain partner and aggregator for pharmaceutical products, medical equipment, and surgical consumables. Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Entero Healthcare Solutions consolidated net profit rises 221.79% in the June 2024 quarter

Net profit of Entero Healthcare Solutions rose 221.79% to Rs 20.08 crore in the quarter ended June 2024 as against Rs 6.24 crore during the previous quarter ended June 2023. Sales rose 22.00% to Rs 1097.04 crore in the quarter ended June 2024 as against Rs 899.20 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1097.04899.20 22 OPM %2.752.87 - PBDT33.9112.80 165 PBT27.306.86 298 NP20.086.24 222 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Entero Healthcare Solutions to conduct board meeting

Entero Healthcare Solutions will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Entero Healthcare Solutions to hold AGM

Entero Healthcare Solutions announced that the Annual General Meeting (AGM) of the company will be held on 28 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live